Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US FDA Warns Docs On Gastric Balloon Adverse Events

Executive Summary

Gastric balloons from ReShape Medical and Apollo Endosurgery have been tied to pancreatitis and problems caused by over-inflation, the agency says.


Related Content

Market Intel: Intragastric Balloons And Other Innovations To Inflate Weight Loss Devices Market
Gastric Balloon-Makers Respond To US FDA Warning
US FDA Warns of Deaths Tied To Gastric Balloons
Apollo Endosurgery Seeks To Raise $31m In Share Sale
Obesity 2016: Minimally Invasive Bariatric Devices Gaining Steam


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts